| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
RLAY
Relay Therapeutics
|
Aug 07, 2026 | BUY |
Strong Buy
+9.3% avg upside
21 analysts
|
$25.00
22.38% Upside
|
+4.5% | · |
|
ROIV
Roivant Sciences
|
Aug 07, 2026 | HOLD |
Strong Buy
-2.0% avg upside
17 analysts
|
$37.00
1.87% Upside
|
+2.8% | · |
|
SUPN
Supernus Pharmaceuticals
|
Jul 13, 2026 | BUY |
Strong Buy
+17.2% avg upside
9 analysts
|
$63.00
30.92% Upside
|
+1.9% | · |
|
CCCC
C4 Therapeutics
|
Oct 31, 2023 | HOLD |
Strong Buy
+323.4% avg upside
19 analysts
|
— | +257.7% | · |
|
FHTX
Foghorn Therapeutics
|
Oct 06, 2023 | HOLD |
Strong Buy
+80.8% avg upside
17 analysts
|
— | +78.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.